Injectable Drug Delivery Equipment is a delivery equipment for injecting drugs from reagents to the human body. The increase in chronic diseases has led to an increased demand for these devices.
This report contains market size and forecasts of Injectable Drug Delivery Equipment in global, including the following market information:
- Global Injectable Drug Delivery Equipment Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Injectable Drug Delivery Equipment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Injectable Drug Delivery Equipment companies in 2021 (%)
The global Injectable Drug Delivery Equipment market was valued at 500770 million in 2021 and is projected to reach US$ 879230 million by 2028, at a CAGR of 8.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Conventional Drug Delivery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Drug Delivery Equipment include Pfizer, Inc., Baxter International, Inc., Schott AG, Becton Dickinson, Terumo Corporation, Elcam Medical, Molex (Phillips-Medisize), West Pharmaceutical Service and Biocorp, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injectable Drug Delivery Equipment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Drug Delivery Equipment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Drug Delivery Equipment Market Segment Percentages, by Type, 2021 (%)
- Conventional Drug Delivery
- Novel Drug Delivery
- Others
Global Injectable Drug Delivery Equipment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Drug Delivery Equipment Market Segment Percentages, by Application, 2021 (%)
- Hospitals and Clinics
- Homecare
- Others
Global Injectable Drug Delivery Equipment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Drug Delivery Equipment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Injectable Drug Delivery Equipment revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Injectable Drug Delivery Equipment revenues share in global market, 2021 (%)
- Key companies Injectable Drug Delivery Equipment sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Injectable Drug Delivery Equipment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer, Inc.
- Baxter International, Inc.
- Schott AG
- Becton Dickinson
- Terumo Corporation
- Elcam Medical
- Molex (Phillips-Medisize)
- West Pharmaceutical Service
- Biocorp
- Haselmeier
- SHL Group
